- R&I-1429
- February 2024
- 234
- PPT, PDF, WORD, EXCEL
- Healthcare & Life Sciences
address
1820 Avenue M, Brooklyn, NY, 11230, United States
mail address
sales@reportsandinsights.comContact no.
Market Overview:
"The drug designing tools market size reached US$ 3.0 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 6.3 billion in 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032."
|
Report Attributes |
Details |
|
Base Year |
2023 |
|
Forecast Years |
2024-2032 |
|
Historical Years |
2021-2023 |
|
Market Growth Rate (2024-2032) |
8.5% |
Drug designing tools are software applications or computational models employed in pharmaceutical research. They are used to predict, analyze, and enhance interactions between small molecules (drugs) and biological targets like proteins or nucleic acids. These tools use algorithms and databases to simulate molecular structures, predict binding affinities, and evaluate the pharmacokinetic properties of potential drug candidates. By utilizing these tools, researchers can accelerate the drug discovery process, decrease costs, and increase the chances of identifying effective therapies for a range of diseases.
The market for drug designing tools is expanding rapidly, propelled by factors such as rising demand for new and efficient drugs, increased use of computational methods in drug discovery, and technological advancements. These tools are essential for speeding up drug development processes by helping researchers predict and enhance interactions between drugs and their targets. Moreover, the market is driven by the growing incidence of chronic diseases and the demand for personalized medicine. Competition in the market is fierce, with major players concentrating on creating innovative solutions to meet the changing requirements of the pharmaceutical sector.
Drug Designing Tools Market Trends and Drivers:
The drug designing tools market is shaped by various trends and drivers. One significant trend is the increasing integration of artificial intelligence (AI) and machine learning (ML) algorithms, which enhance the accuracy of drug-target interaction predictions and expedite the discovery of potential drug candidates. Another driving force is the escalating emphasis on personalized medicine, spurring the demand for tools capable of tailoring treatments to individual patients based on their genetic profiles and other characteristics. Moreover, the emergence of biologics and gene therapies has necessitated the development of tools capable of designing and optimizing these intricate therapeutics. Regulatory efforts aimed at accelerating drug approvals and reducing development costs also influence the market dynamics.
The drug designing tools market growth is influenced by several factors which include the growing incidence of chronic diseases, rising demand for personalized medicine, and increasing use of computational approaches in drug discovery. Technological advancements, particularly in artificial intelligence and machine learning, are also significant drivers, enabling more effective and precise drug design processes. Moreover, there is a growing need to reduce drug development costs and timelines, which is boosting the demand for these tools due to their potential to streamline the drug discovery process and enhance the success rate of new drug candidates.
Drug Designing Tools Restraining Factors:
Several factors restrain the drug designing tools market. High costs of software and computational resources present barriers to entry for smaller research institutions and companies. Additionally, the complexity of drug-target interactions and limitations of current computational models can reduce the accuracy and reliability of predictions made by these tools. Regulatory hurdles, such as the necessity to validate computational predictions with experimental data, can also impede their adoption. Furthermore, a shortage of skilled professionals capable of effectively using and interpreting the results of these tools is a significant challenge in certain regions.
Drug Designing Tools Market Opportunities:
The drug designing tools market is witnessing notable growth opportunities driven by increasing demand for innovative drug molecules, growing prevalence of chronic diseases, and technological advancements. Factors such as the integration of AI and machine learning in drug discovery, the shift toward personalized medicine, and the expansion of biopharmaceutical industries in emerging markets are further propelling market growth. The market is marked by fierce competition and rapid technological progress, with major players concentrating on strategic partnerships, acquisitions, and product enhancements to sustain their market presence.
Drug Designing Tools Market Segmentation:
By Solution
- Multi Databases
- Virtual Screening Tools
- Structure Designing/ Building Tools
- Predictive Analytics
- Model Building Tools
- Others
On the basis of solution, the drug designing market is categorised on the basis on multi databases, virtual screening tools, structure designing/ building tools, predictive analytics, model building tools and others. Among these, virtual screening tools are widely regarded as the dominant solution in the drug designing tool market. These tools are pivotal in the initial phases of drug discovery, swiftly and effectively screening extensive compound libraries to pinpoint potential drug candidates. Utilizing computational methods, virtual screening tools forecast the probability of a compound binding to a target protein, aiding researchers in prioritizing compounds for subsequent testing. Given their ability to hasten the drug discovery process, these tools are extensively employed in pharmaceutical companies and research institutions.
By Application
- Chemical Screening
- Molecular Modeling/ Homology modeling
- Target Prediction
- Binding Site Prediction
- Docking
- Energy Minimization
- Others
On the basis of application, it is categorised on the basis of chemical screening, molecular modeling/homology modeling, target prediction, binding site prediction, docking, energy minimization, and others. Among these, Homology modeling, also known as molecular modeling, stands out as the dominant sub-segment in the Drug Designing Tools Market for application segment. This approach involves the use of computer-based models to comprehend the functions and interactions of molecular structures. It plays a pivotal role in drug discovery by predicting the three-dimensional structure of biological macromolecules, such as proteins and nucleic acids, which is crucial for designing new drugs. These tools find extensive use in the pharmaceutical industry and research institutions to accelerate the drug development process and improve the efficiency of target identification and validation.
By Region:
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Poland
- Benelux
- Nordic
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- ASEAN
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
- Israel
- Rest of MEA
North America leads the drug designing tools market due to its well-established pharmaceutical industry, robust research and development infrastructure, and significant investments in advanced technologies. The United States, in particular, is a key player, with many pharmaceutical and biotechnology companies driving innovation in drug discovery and development. The region also benefits from top academic and research institutions, along with supportive government initiatives and funding, all contributing to the market's growth in North America.
Leading Drug Designing Tools Manufacturers & Competitive Landscape:
The drug designing tools market is highly competitive, with several key players vying for market share and actively engaging in strategic initiatives. These companies focus on product innovation, technological advancements, and expanding their product portfolios to gain a competitive edge. These companies are continuously investing in research and development activities to enhance their product offerings and cater to the evolving needs of customers in terms of efficiency, performance, and sustainability.
These companies include:
- Agilent Technologies
- Schrödinger LLC
- Biovia Corporation
- BioSolveIT GmbH
- ChemAxon
- Albany Molecular Research Inc.
- OpenEye Scientific Software Inc.
- XtalPi Inc.
Recent News and Development
- December 2023: MilliporeSigma launched AIDDISO, an innovative drug discovery software that is the first software as a service (SaaS) platform. AIDDISO is designed to connect virtual molecule design with real-world manufacturability by integrating with the Synthia retrosynthesis software application programming interface (API).
Research Scope
|
Report Metric |
Report Details |
|
Market size available for the years   |
2021-2023 |
|
Base Year |
2023 |
|
Forecast Period       |
2024-2032 |
|
Compound Annual Growth Rate (CAGR) |
8.5% |
|
Segment covered |
Solution, Application and regions. |
|
Regions Covered |
North America: The U.S. & Canada Latin America: Brazil, Mexico, Argentina, & Rest of Latin America Asia Pacific: China, India, Japan, Australia & New Zealand, ASEAN, & Rest of Asia Pacific Europe: Germany, The U.K., France, Spain, Italy, Russia, Poland, BENELUX, NORDIC, & Rest of Europe The Middle East & Africa: Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, and Rest of MEA |
|
Fastest Growing Country in Europe |
Germany |
|
Largest Market |
North America |
|
Key Players |
Agilent Technologies, Schrödinger LLC, Biovia Corporation, BioSolveIT GmbH, ChemAxon, Albany Molecular Research Inc., OpenEye Scientific Software Inc. and XtalPi Inc. |
1. Global Drug Designing Tools Application Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Drug Designing Tools Application Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Drug Designing Tools Application Market Snapshot
2.4. Global Drug Designing Tools Application Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Drug Designing Tools Application Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Drug Designing Tools Application Market, By Solution
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Solution
3.1.2. BPS Analysis, By Solution
3.2. Market Revenue (US$Mn) Forecast, By Solution
3.2.1. Multi Databases
3.2.2. Virtual Screening Tools
3.2.3. Structure Designing/ Building Tools
3.2.4. Predictive Analytics
3.2.5. Model Building Tools
3.2.6. Others
3.3. Global Drug Designing Tools Application Market Attractiveness Index, By Solution
4. Global Drug Designing Tools Application Market, By Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Application
4.1.2. BPS Analysis, By Application
4.2. Market Revenue (US$Mn) Forecast, By Application
4.2.1. Chemical Screening
4.2.2. Molecular Modelling/ Homology modelling
4.2.3. Target Prediction
4.2.4. Binding Site Prediction
4.2.5. Docking
4.2.6. Energy Minimization
4.2.7. Others
4.3. Global Drug Designing Tools Application Market Attractiveness Index, By Application
5. Global Drug Designing Tools Application Market, By End User
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End User
5.1.2. BPS Analysis, By End User
5.2. Market Revenue (US$Mn) Forecast, By End User
5.2.1. Pharmaceutical Companies
5.2.2. Biotechnology Companies
5.2.3. Academic and Research Institutes
5.2.4. Contract Research Organizations
5.2.5. Others
5.3. Global Drug Designing Tools Application Market Attractiveness Index, By End User
6. Global Drug Designing Tools Application Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Drug Designing Tools Application Market Attractiveness Index, By Region
7. North America Drug Designing Tools Application Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Drug Designing Tools Application Market
7.2.2. Canada Drug Designing Tools Application Market
7.3. North America Drug Designing Tools Application Market, By Solution
7.3.1. Multi Databases
7.3.2. Virtual Screening Tools
7.3.3. Structure Designing/ Building Tools
7.3.4. Predictive Analytics
7.3.5. Model Building Tools
7.3.6. Others
7.4. North America Drug Designing Tools Application Market, By Application
7.4.1. Chemical Screening
7.4.2. Molecular Modelling/ Homology modelling
7.4.3. Target Prediction
7.4.4. Binding Site Prediction
7.4.5. Docking
7.4.6. Energy Minimization
7.4.7. Others
7.5. North America Drug Designing Tools Application Market, By End User
7.5.1. Pharmaceutical Companies
7.5.2. Biotechnology Companies
7.5.3. Academic and Research Institutes
7.5.4. Contract Research Organizations
7.5.5. Others
7.6. North America Drug Designing Tools Application Market Attractiveness Index
7.6.1. By Country
7.6.2. By End User
7.6.3. By Application
7.6.4. By Solution
8. Latin America Drug Designing Tools Application Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Drug Designing Tools Application Market
8.2.2. Mexico Drug Designing Tools Application Market
8.2.3. Argentina Drug Designing Tools Application Market
8.2.4. Rest of Latin America Drug Designing Tools Application Market
8.3. Latin America Drug Designing Tools Application Market, By Solution
8.3.1. Multi Databases
8.3.2. Virtual Screening Tools
8.3.3. Structure Designing/ Building Tools
8.3.4. Predictive Analytics
8.3.5. Model Building Tools
8.3.6. Others
8.4. Latin America Drug Designing Tools Application Market, By Application
8.4.1. Chemical Screening
8.4.2. Molecular Modelling/ Homology modelling
8.4.3. Target Prediction
8.4.4. Binding Site Prediction
8.4.5. Docking
8.4.6. Energy Minimization
8.4.7. Others
8.5. Latin America Drug Designing Tools Application Market, By End User
8.5.1. Pharmaceutical Companies
8.5.2. Biotechnology Companies
8.5.3. Academic and Research Institutes
8.5.4. Contract Research Organizations
8.5.5. Others
8.6. Latin America Drug Designing Tools Application Market Attractiveness Index
8.6.1. By Country
8.6.2. By End User
8.6.3. By Application
8.6.4. By Solution
9. Europe Drug Designing Tools Application Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Drug Designing Tools Application Market
9.2.2. Germany Drug Designing Tools Application Market
9.2.3. Italy Drug Designing Tools Application Market
9.2.4. France Drug Designing Tools Application Market
9.2.5. Spain Drug Designing Tools Application Market
9.2.6. Russia Drug Designing Tools Application Market
9.2.7. Poland Drug Designing Tools Application Market
9.2.8. BENELUX Drug Designing Tools Application Market
9.2.9. NORDIC Drug Designing Tools Application Market
9.2.10. Rest of Europe Drug Designing Tools Application Market
9.3. Europe Drug Designing Tools Application Market, By Solution
9.3.1. Multi Databases
9.3.2. Virtual Screening Tools
9.3.3. Structure Designing/ Building Tools
9.3.4. Predictive Analytics
9.3.5. Model Building Tools
9.3.6. Others
9.4. Europe Drug Designing Tools Application Market, By Application
9.4.1. Chemical Screening
9.4.2. Molecular Modelling/ Homology modelling
9.4.3. Target Prediction
9.4.4. Binding Site Prediction
9.4.5. Docking
9.4.6. Energy Minimization
9.4.7. Others
9.5. Europe Drug Designing Tools Application Market, By End User
9.5.1. Pharmaceutical Companies
9.5.2. Biotechnology Companies
9.5.3. Academic and Research Institutes
9.5.4. Contract Research Organizations
9.5.5. Others
9.6. Europe Drug Designing Tools Application Market Attractiveness Index
9.6.1. By Country
9.6.2. By End User
9.6.3. By Application
9.6.4. By Solution
10. Asia Pacific Drug Designing Tools Application Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Drug Designing Tools Application Market
10.2.2. India Drug Designing Tools Application Market
10.2.3. Japan Drug Designing Tools Application Market
10.2.4. Australia and New Zealand Drug Designing Tools Application Market
10.2.5. South Korea Drug Designing Tools Application Market
10.2.6. ASEAN Drug Designing Tools Application Market
10.2.7. Rest of Asia Pacific Drug Designing Tools Application Market
10.3. Asia Pacific Drug Designing Tools Application Market, By Solution
10.3.1. Multi Databases
10.3.2. Virtual Screening Tools
10.3.3. Structure Designing/ Building Tools
10.3.4. Predictive Analytics
10.3.5. Model Building Tools
10.3.6. Others
10.4. Asia Pacific Drug Designing Tools Application Market, By Application
10.4.1. Chemical Screening
10.4.2. Molecular Modelling/ Homology modelling
10.4.3. Target Prediction
10.4.4. Binding Site Prediction
10.4.5. Docking
10.4.6. Energy Minimization
10.4.7. Others
10.5. Asia Pacific Drug Designing Tools Application Market, By End User
10.5.1. Pharmaceutical Companies
10.5.2. Biotechnology Companies
10.5.3. Academic and Research Institutes
10.5.4. Contract Research Organizations
10.5.5. Others
10.6. Asia Pacific Drug Designing Tools Application Market Attractiveness Index
10.6.1. By Country
10.6.2. By End User
10.6.3. By Application
10.6.4. By Solution
11. Middle East Drug Designing Tools Application Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Drug Designing Tools Application Market
11.2.2. Israel Drug Designing Tools Application Market
11.2.3. Oman Drug Designing Tools Application Market
11.2.4. Rest of Middle East Drug Designing Tools Application Market
11.3. Middle East Drug Designing Tools Application Market, By Solution
11.3.1. Multi Databases
11.3.2. Virtual Screening Tools
11.3.3. Structure Designing/ Building Tools
11.3.4. Predictive Analytics
11.3.5. Model Building Tools
11.3.6. Others
11.4. Middle East Drug Designing Tools Application Market, By Application
11.4.1. Chemical Screening
11.4.2. Molecular Modelling/ Homology modelling
11.4.3. Target Prediction
11.4.4. Binding Site Prediction
11.4.5. Docking
11.4.6. Energy Minimization
11.4.7. Others
11.5. Middle East Drug Designing Tools Application Market, By End User
11.5.1. Pharmaceutical Companies
11.5.2. Biotechnology Companies
11.5.3. Academic and Research Institutes
11.5.4. Contract Research Organizations
11.5.5. Others
11.6. Middle East Drug Designing Tools Application Market Attractiveness Index
11.6.1. By Country
11.6.2. By End User
11.6.3. By Application
11.6.4. By Solution
12. Africa Drug Designing Tools Application Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Drug Designing Tools Application Market
12.2.2. Egypt Drug Designing Tools Application Market
12.2.3. North Africa Drug Designing Tools Application Market
12.2.4. Rest of Africa Drug Designing Tools Application Market
12.3. Africa Drug Designing Tools Application Market, By Solution
12.3.1. Multi Databases
12.3.2. Virtual Screening Tools
12.3.3. Structure Designing/ Building Tools
12.3.4. Predictive Analytics
12.3.5. Model Building Tools
12.3.6. Others
12.4. Africa Drug Designing Tools Application Market, By Application
12.4.1. Chemical Screening
12.4.2. Molecular Modelling/ Homology modelling
12.4.3. Target Prediction
12.4.4. Binding Site Prediction
12.4.5. Docking
12.4.6. Energy Minimization
12.4.7. Others
12.5. Africa Drug Designing Tools Application Market, By End User
12.5.1. Pharmaceutical Companies
12.5.2. Biotechnology Companies
12.5.3. Academic and Research Institutes
12.5.4. Contract Research Organizations
12.5.5. Others
12.6. Africa Drug Designing Tools Application Market Attractiveness Index
12.6.1. By Country
12.6.2. By End User
12.6.3. By Application
12.6.4. By Solution
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Agilent Technologies
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Albany Molecular Research Inc.
14.3.3. BioSolveIT GmbH
14.3.4. Biovia Corporation
14.3.5. ChemAxon
14.3.6. COSMOlogic GmbH & Co.
14.3.7. Novo Informatics Pvt. Ltd.
14.3.8. OpenEye Scientific Software Inc.
14.3.9. Schrödinger LLC
14.3.10. XtalPi Inc.
15. Acronyms
Frequently Asked Question
At what CAGR will the drug designing tools market expand?
The market is anticipated to rise at 8.5% through 2032.
What is the forecast period of the market?
Market is forecasted from the year 2024 to 2032.
What software is used for drug designing?
The software used for drug designing are Insight II, Discovery Studio, Materials Studio, Accord, Prime, and Jaguar.
How is AI used in drug creation?
AI can be used to virtually screen and optimize compounds, estimate their bio-activities, and predict protein-drug interactions.
What are some key factors driving revenue growth of the drug designing tools market?
Some key factors driving drug designing tools market revenue growth include advancement in technology, growing prevalence of chronic diseases, and increasing R&D pharmaceuticals.
What are some major challenges faced by companies in the drug designing tools market?
Companies face challenges such as high cost of drug development, regulatory hurdles, and integration of AI and ML.
How is the competitive landscape in the drug designing tools market?
The market is competitive, with key players focusing on technological advancements, product innovation, and strategic partnerships. Factors such as product quality, reliability, after-sales services, and customization capabilities play a significant role in determining competitiveness.
Who are the leading key players in drug designing tools market?
The leading key players in the drug designing tools market are Agilent Technologies, Albany Molecular Research Inc, BioSolveIT GmbH, Biovia Corporation, ChemAxon, COSMOlogic GmbH & Co, Novo Informatics Pvt. Ltd, OpenEye Scientific Software Inc, Schrödinger LLC and XtalPi Inc.